Atmanirbhar Bharat 2.0 push: Amid Middle East conflict, India working on self-reliance in energy, nuclear power

PM Modi has asked ministries and government departments to review the evolving situation and draw up both immediate and long-term plans. (AI image) Atmanirbhar 2.0: The Middle East conflict has led India to re-work its self-reliance strategy to shield key supply chains and strengthen energy security in response to the global economic disruption triggered by…

Read More

Saudi Arabia Financial Aid To Pakistan: Pakistan gets $3 billion from Saudi Arabia as ‘support’ to shore up forex reserves as UAE debt looms

Pakistan gets $3bn from Saudi Arabia as ‘support’ to shore up forex reserves as UAE debt looms Saudi Arabia has provided new financial help to Pakistan with an extra $3 billion deposit. It has also extended an existing $5 billion loan. This support is important for Pakistan as it struggles to meet its growing debt…

Read More

Asian stocks today: Markets rally as hopes of US-Iran talks lift sentiment, oil prices ease

File photo (Picture credit: AP) Asian markets rose on Wednesday, following strong gains on Wall Street. Lower oil prices and renewed hopes for talks between the United States and Iran increased investor confidence.MSCI’s broadest index of Asia-Pacific shares outside Japan rose 1.5% to a six-week high, while Japan’s Nikkei gained 1.2%, inching closer to its…

Read More

Stock market today (April 15, 2026): Nifty50 opens above 24,200; BSE Sensex rallies over 1,200 points as oil prices drop on US-Iran peace talks optimism

Stock market today (AI image) Stock market today: Sensex and Nifty50 rallied strongly in opening trade on Wednesday after optimism surrounding renewed US-Iran peace talks led oil prices to drop. While Nifty50 went above 24,200, BSE Sensex rose over 1,200 points. At 9:17 AM, Nifty50 was at around 24,223.45, up 381 points or 1.60%. BSE…

Read More

`Indian pharma must balance generics with innovation’

NEW DELHI: India’s pharmaceutical industry must focus on both generics and innovative products, as well as develop products specially tailored for the country’s patient needs. Domestic companies particularly smaller to mid-sized players can carve out a strong role in rare diseases and niche patient segments, where agility and specialised research can drive meaningful breakthroughs, pharma…

Read More